FERRIPROX is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Deferiprone.
| Product ID | 10122-104_287670b2-60ba-4095-9fe3-7fab114bfc64 | 
| NDC | 10122-104 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | FERRIPROX | 
| Generic Name | Deferiprone | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2020-05-19 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA212269 | 
| Labeler Name | Chiesi USA, Inc. | 
| Substance Name | DEFERIPRONE | 
| Active Ingredient Strength | 1000 mg/1 | 
| Pharm Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2020-05-19 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA212269 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2020-05-19 | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 10122-100 | FERRIPROX | deferiprone | 
| 10122-101 | FERRIPROX | deferiprone | 
| 10122-103 | FERRIPROX | DEFERIPRONE | 
| 10122-104 | FERRIPROX | deferiprone | 
| 52609-0006 | FERRIPROX | deferiprone | 
| 52609-0007 | FERRIPROX | deferiprone | 
| 52609-4502 | FERRIPROX | deferiprone | 
| 0054-0576 | Deferiprone | Deferiprone | 
| 0054-0711 | Deferiprone | Deferiprone | 
| 51672-4196 | Deferiprone | Deferiprone | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() FERRIPROX  75719191  2550510 Live/Registered  | 
        APOTEX INC.  1999-05-28  |